AzTrials
AzTrials

Patellofemoral Pain SyndromeNCT03918863

Neuromuscular Electrical Stimulation on Patellofemoral Pain

A study testing Neuromuscular electrical stimulation and Exercise in people with Patellofemoral Pain Syndrome, run by Universidade Federal do Rio Grande do Norte at 2 sites in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Objective this study is to analyze the effects of an intervention protocol with neuromuscular electrical stimulation in the vastus medialis obliquus and gluteus medius (GM) associated with exercises on electromyographic activity, muscle performance, self-reported functionality and pain of women with patellofemoral… Read more about this study

Who is it for?
Ages 18 to 30 years, women only
Conditions the study is for
Patellofemoral Pain Syndrome
What is being tested?
Neuromuscular electrical stimulation and Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
2 sitesBrazil
Study dates
24 Jun 2019to Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Present anterior or retropatellar pain during at least two of the following functional activities: sitting for long periods, going up or down stairs, running, kneeling down, crouching or jumping;
  • A minimum pain score of three on the numerical pain scale, at the last 24 hours, with insidious and non-traumatic onset of symptoms for at least one month.

Who cannot join

  • History of surgery, trauma or an osteomioarticular system injury in the lower limbs in the last six months;
  • Other pathology associated with the knee joint and could not have performed physical therapy treatment in the last twelve weeks;
  • Body mass index greater than 30;
  • Pregnancy or breastfeeding;
  • Contraindications for the application of neuromuscular electrical stimulation;
  • Intolerance or non-acceptance of electric current;
  • Missing more than two intervention sessions.

Trial locations and contacts

2 sites in 1 country.

Jamilson S Brasileiro, PhD contact

55+848433422008

brasileiro@ufrnet.br

Brazil2 sites, 2 recruiting
  • Universidade Federal do Rio Grande do Norte

    Natal, Rio Grande do Norte, 59078-970

    Jamilson Simões Brasileiro, PhD, +55 84 3342-2008, brasileiro@ufrnet.br

    Recruiting
  • Federal University of Rio Grande do Norte

    Natal, Rio Grande do Norte, 59140-840

    Jamilson S Brasileiro, PhD, +55 84 3342-2008, brasileiro@ufrnet.br

    Recruiting

Other trials in Brazil

About this study

Official title: Effects of a Neuromuscular Electrical Stimulation Protocol in Women With Patellofemoral Pain

Objective this study is to analyze the effects of an intervention protocol with neuromuscular electrical stimulation in the vastus medialis obliquus and gluteus medius (GM) associated with exercises on electromyographic activity, muscle performance, self-reported functionality and pain of women with patellofemoral pain.

Read the detailed description

This is a randomized, blinded trial in which 40 women, aged 18-30 years, will be randomized into 2 groups: Stimulation and Exercise Group (SEG) - will perform an exercise protocol associated with stimulation in the vastus medialis (VM) and gluteus medius (GM) muscles. Exercises Group (ExG) - will perform the same protocol of exercises of the previous group, however, without association with neuromuscular electrical stimulation. The intervention will occur twice a week for eight weeks. All volunteers will be submitted to the evaluation of the electromyographic activity of the VM, the GM and the vastus lateralis, the dynamometric parameters, the intensity of the pain and the functionality, in four moments: 72h hours before the beginning of the intervention; after 4 weeks of intervention; after 8 weeks of intervention; after 16 weeks from the start of the intervention (eight weeks after the end of the protocol). In this way, the investigators will investigate the applicability of the proposed trial with the use of neuromuscular electrical stimulation and identify the effects of this resource in the treatment of PFP.

Being tested
Neuromuscular electrical stimulation, Exercise
Keywords
electromyography, physiotherapy, knee, quadriceps muscle
Medical subject headings
Patellofemoral Pain Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neuromuscular electrical stimulationOther

    Also called Muscular eletrical stimulation

    Exercise protocol associated with neuromuscular electrical stimulation on vastus medialis and gluteus medius. Parameters: rectangular pulse shape, biphasic, symmetrical, pulse duration of 200μs, interbust interval of 10ms and frequency of 2.500Hz modulated in 50 bursts.

  • ExerciseOther

    Same protocol of exercises of the other group, without association of electrical stimulation.

Study groups in NCT03918863
Study groupRoleWhat they receive
Neuromuscular electrical stimulationExperimental8-week exercise program, twice a week, with neuromuscular eletrical stimulation on vastus medialis and gluteus medius.
Receives: Other: Neuromuscular electrical stimulation
ExerciseActive comparator8-week exercise program, twice a week.
Receives: Other: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knee pain

    Evaluation of pain level in the knee using the Numerical Pain Scale, graded from 0 to 10, where 0 indicates absence of pain and 10 indicates the worst pain imaginable.

    Measured: Change from baseline in knee pain at 8 weeks.

  2. Knee function

    Evaluation of knee function using the Anterior Knee Pain Scale, that is a questionnaire encompassing 13 items related to different levels of knee function, with scores ranging from zero (representing the highest possible deficit) to 100 (meaning that the subject does not present any deficit).

    Measured: Change from baseline in knee function at 8 weeks.

Secondary outcomes (6)
  1. Root Mean Square (RMS)

    Evaluation of the amplitude oh the electromyographic sinal (RMS) of vastus medialis, vastus lateralis and gluteus medius.

    Measured: Change from baseline in RMS at 8 weeks.

  2. Time of muscle activation (Onset)

    Evaluation of time of muscle activation electromyographic (onset) of vastus medialis, vastus lateralis and gluteus medius.

    Measured: Change from baseline in onset of the electromyographic at 8 weeks.

  3. Isokinetic performance

    Evaluation of isokinetic variable peak torque normalized for body weight (%) of knee extensors and hip abductors.

    Measured: Change from baseline in peak torque normalized for body weight at 8 weeks.

  4. Isokinetic performance

    Evaluation of isokinetic variable average peak torque (Nm) of knee extensors and hip abductors.

    Measured: Change from baseline in average peak torque at 8 weeks.

  5. Isokinetic performance

    Evaluation of isokinetic variable average power (W) of knee extensors and hip abductors.

    Measured: Change from baseline in average power at 8 weeks.

  6. Isokinetic performance

    Evaluation of isokinetic variable total work (J) of knee extensors and hip abductors.

    Measured: Change from baseline in total work at 8 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2019
  2. Study start24 Jun 2019
  3. Primary completionDec 2020 (estimated)
  4. Study completionDec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03918863
Sponsor's protocol ID
SAM2019
Status last verified
May 2019
First submitted
2 Apr 2019
Last updated
22 Oct 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Melo SA, Macedo LB, Bullhoes LCC, Cavalcanti RL, Azevedo Rodolfo JI, Brasileiro JS. Effects of neuromuscular electrical stimulation on patellofemoral pain: A randomized controlled trial. J Bodyw Mov Ther. 2024 Jul;39:390-397. doi: 10.1016/j.jbmt.2024.03.022. Epub 2024 Mar 19.

    PubMed 38876657

Questions about this trial

What is this clinical trial studying?

A study testing Neuromuscular electrical stimulation and Exercise in people with Patellofemoral Pain Syndrome, run by Universidade Federal do Rio Grande do Norte at 2 sites in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jamilson S Brasileiro, PhD (55+848433422008, brasileiro@ufrnet.br), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knee pain (time frame: Change from baseline in knee pain at 8 weeks.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03918863, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in